Oxb–302 12 February 2017 Continue reading OXB–302 Gene-based immunotherapy targeting blood cancer Status: Pre–Clinical complete Immunotherapy OXB-302 is our lead programme which targets 5T4, this is currently being investigated in Acute Myeloid Leukaemia.